20.62 USD
↘ 2.75 (11.77%)AT CLOSE (11:59 AM EDT)
Braveheart Bio, Inc. Common Stock
BRVENASDAQ • USD
21.00
↗ 0.38 (1.84%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
21.00
↗ 0.38 (1.84%)
Market: CLOSED
BRVE is currently priced at $20.62. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Sep 25, 2026.
Open?$23.58
High?$23.86
Low?$20.53
Prev. Close?$23.37
Volume?471.9K
Avg. Volume?N/A
VWAP?$21.28
Bid / Ask
Bid?$20.15 × 100
Ask?$22.00 × 600
Spread?$1.85
Midpoint?$21.08
Valuation & Ratios
Market Cap?1.9B
Shares Out?N/A
Float?56.2M
Float %?62.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Employees
N/A
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-08-06
Address
ONE LETTERMAN DR.
SAN FRANCISCO, CA 94129
Phone: (415) 707-6312
SAN FRANCISCO, CA 94129
Phone: (415) 707-6312
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?4.38%Low
Short Interest?2.5M
Days to Cover?7.5
Free Float56.2M
Avg Daily Volume328.4K
Settlement Date2026-09-15